Literature DB >> 11246628

Who defines Barrett's oesophagus: endoscopist or pathologist?

S E Attwood1, C D Morris.   

Abstract

The diagnosis of Barrett's oesophagus has traditionally relied on the identification of a 3-cm segment of endoscopically abnormal epithelium (columnar) in the distal oesophagus. More recently, the presence of intestinal metaplasia has become essential. The importance of the definition relates to the identification of the risk of cancer development. These factors are discussed in the context of the rising incidence of adenocarcinoma, and the relative contributions of endoscopists and pathologists in determining likely progression are explored. We also discuss the advances in endoscopic technology that may aid the endoscopist in predicting malignant progression.

Entities:  

Mesh:

Year:  2001        PMID: 11246628     DOI: 10.1097/00042737-200102000-00002

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  Barrett's esophagus and the increasing role of endoluminal therapy.

Authors:  Michael S Smith; Charles J Lightdale
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

Review 2.  Endoscopic therapy for Barrett's oesophagus.

Authors:  H Barr; N Stone; B Rembacken
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 3.  New developments in the endoscopic surveillance of Barrett's oesophagus.

Authors:  J J G H M Bergman; G N J Tytgat
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 4.  Natural history of Barrett's esophagus.

Authors:  Rao Milind; Stephen E Attwood
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.